Neuroone Medical Technologies (NMTC) Assets Average (2016 - 2025)
Neuroone Medical Technologies (NMTC) has disclosed Assets Average for 11 consecutive years, with $9.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 63.2% year-over-year to $9.7 million, compared with a TTM value of $9.7 million through Dec 2025, up 63.2%, and an annual FY2025 reading of $8.1 million, up 19.96% over the prior year.
- Assets Average was $9.7 million for Q4 2025 at Neuroone Medical Technologies, down from $10.8 million in the prior quarter.
- Across five years, Assets Average topped out at $15.6 million in Q1 2022 and bottomed at $5.1 million in Q3 2024.
- Average Assets Average over 5 years is $8.9 million, with a median of $8.7 million recorded in 2021.
- The sharpest move saw Assets Average skyrocketed 207.08% in 2021, then plummeted 49.48% in 2023.
- Year by year, Assets Average stood at $12.6 million in 2021, then decreased by 10.51% to $11.2 million in 2022, then tumbled by 38.09% to $7.0 million in 2023, then fell by 14.77% to $5.9 million in 2024, then surged by 63.2% to $9.7 million in 2025.
- Business Quant data shows Assets Average for NMTC at $9.7 million in Q4 2025, $10.8 million in Q3 2025, and $7.6 million in Q2 2025.